drugset / Trial / NCT07028268
A Trial of SHR-2017 Injection in Patients With Bone Metastases From Solid Tumors
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The study is being conducted to evaluate the efficacy, and safety of SHR-2017 Injection in Patients with Bone Metastases from Solid Tumors. To explore the reasonable dosage of SHR-2017 Injection for Bone Metastases from Solid Tumors
Timeline
- Start
- 2025-06-24
- Primary completion
- 2025-12
- Completion
- 2027-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Denosumab | Monoclonal antibody | — | — |
| Subject | SHR-2017 | Unknown | — | — |
Indications
No indication recorded.